🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kendrith M. Rowland

Carle Foundation Hospital

ORCID: 0000-0003-0640-6733

Also affiliated with University of Illinois Urbana-Champaign, Illinois College, Urbana University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)”.

Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)

Journal of Clinical Oncology(2024)10.1200/jco.23.01100

N/A

0.648DataRank · unranked

21 citations

Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King +6 more

Feasibility of a digital medicine program in optimizing opioid pain control in cancer patients (SWOG S1916).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps12126

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Amy K. Darke, Joseph M. Unger, Mina S. Sedrak, Barbara Segarra-Vázquez +9 more

Phase 3 randomized placebo-controlled trial of donepezil for late cancer-related cognitive impairment in breast cancer survivors exposed to chemotherapy from the Wake Forest NCORP Research Base REMEMBER trial (WF97116).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12004

N/A

0DataRank · unranked

7 citations

Emily V. Dressler, W. Mark Brown, James L. Wade, Nguyet Le‐Lindqwister, David M. King +6 more

Intergroup randomized phase III study of adjuvant FOLFIRI, FOLFOX, or 5-FU/leucovorin for stage II/III rectal cancer: ECOG-ACRIN E3201

The Oncologist(2025)10.1093/oncolo/oyaf416

N/A

0DataRank · unranked

0 citations

Fengmin Zhao, Neal J. Meropol, Bruce J. Giantonio, Robert B. Diasio, Patrick J. Flynn +14 more